<DOC>
	<DOC>NCT00891774</DOC>
	<brief_summary>Approximately 165 subjects with Fitzpatrick Skin Color Types IV, V, and VI and a moderate to deep wrinkle between the corner of the nose and the corner of the mouth, will be treated with EVOLENCE® (an approved collagen filler) to smooth and flatten that wrinkle. They will be observed for 6 months to establish safety of the product as it relates to scarring and changes in skin pigment, and long term effectiveness.</brief_summary>
	<brief_title>Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VI</brief_title>
	<detailed_description>This is an open-label, multi-center, prospective, postmarket study to assess the safety and effectiveness of EVOLENCE® (DP101) in Subjects with Fitzpatrick Skin Color Types IV, V, and VI seeking correction of bilateral facial wrinkles and folds of the nasolabial area. The study will enroll and treat a total of 165 subjects with Fitzpatrick Skin Color Types IV, V and VI who have clinical evidence of moderate to deep bilateral wrinkles in the nasolabial area.</detailed_description>
	<criteria>&gt;18 years of age moderate to deep wrinkle in the NasoLabial fold Fitzpatrick Skin Type IV, V or VI Pregnant or nursing females Hx of allergies to related products history of keloids, active skin disease, or previous augmentation of the treatment area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>